TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Neoadjuvant Nivolumab Plus Ipilimumab Versus Chemotherapy in Resectable Lung Cancer.

Mark M Awad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.